Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Oct 18 - Oct 23
Unlike orforglipron, danuglipron was initially developed as a twice-daily formulation, reflecting its shorter half-life
The Problems with Current GLP-1 Guidelines Traditional medicine waits to prescribe GLP-1 medications until a patients BMI hits 30 (obesity) or 27 with at least one weight-related health condition, such as high blood pressure or high cholesterol
For those who are considering GLP-1s, it helps to understand what is FDA-approved today, what the results look like on average, and what tradeoffs come with pills versus injections
RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis
Talking to experts about the diagnostic process for gastroparesis can help the plaintiffs gather evidence to support their claim that Mounjaro and other GLP-1 manufacturers created an unsafe medication
